Fmr LLC Sells 44,054 Shares of Phreesia, Inc. (NYSE:PHR)

Fmr LLC cut its stake in shares of Phreesia, Inc. (NYSE:PHR) by 0.7% during the third quarter, HoldingsChannel reports. The firm owned 6,697,395 shares of the company’s stock after selling 44,054 shares during the quarter. Fmr LLC owned about 0.12% of Phreesia worth $152,634,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Champlain Investment Partners LLC boosted its stake in Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after buying an additional 97,847 shares during the period. TimesSquare Capital Management LLC boosted its stake in shares of Phreesia by 2.3% during the 3rd quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after purchasing an additional 19,395 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in Phreesia by 3.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 447,239 shares of the company’s stock valued at $10,193,000 after purchasing an additional 16,112 shares during the last quarter. Peregrine Capital Management LLC raised its position in Phreesia by 11.3% in the 2nd quarter. Peregrine Capital Management LLC now owns 354,607 shares of the company’s stock worth $7,518,000 after purchasing an additional 36,047 shares during the period. Finally, Squarepoint Ops LLC raised its position in Phreesia by 56.3% in the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock worth $5,308,000 after purchasing an additional 90,215 shares during the period. 92.10% of the stock is owned by institutional investors.

Insider Activity at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 1,212 shares of the firm’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total value of $25,488.36. Following the completion of the sale, the general counsel now directly owns 119,791 shares in the company, valued at $2,519,204.73. This trade represents a 1.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP David Linetsky sold 1,716 shares of the company’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $39,897.00. Following the transaction, the senior vice president now directly owns 203,318 shares in the company, valued at approximately $4,727,143.50. The trade was a 0.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 29,997 shares of company stock valued at $667,943 over the last quarter. 5.80% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on PHR. JPMorgan Chase & Co. upped their target price on Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Monday, September 9th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a research report on Friday, September 27th. DA Davidson reiterated a “buy” rating and set a $32.00 target price on shares of Phreesia in a research report on Thursday, September 5th. Robert W. Baird upped their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a report on Friday, September 6th. Finally, Truist Financial lifted their price objective on shares of Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a report on Friday, September 6th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $29.42.

Phreesia Stock Performance

Shares of PHR stock opened at $20.92 on Wednesday. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of -11.62 and a beta of 0.98. Phreesia, Inc. has a 52-week low of $14.55 and a 52-week high of $29.16. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The company’s 50 day moving average is $20.35 and its 200 day moving average is $21.80.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.06. The business had revenue of $102.12 million for the quarter, compared to the consensus estimate of $101.76 million. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. On average, sell-side analysts anticipate that Phreesia, Inc. will post -1.23 EPS for the current fiscal year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.